Closed Loop Glucose Control in Patients With Type 2 Diabetes
NCT: NCT05386849 · COMPLETED
Brief Summary
This is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting. The type 2 diabetic subjects in this study will have their glucose controlled to a range of 100-140 mg/dL by a novel artificial intelligence based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals during the 24 hour study period.
Frequently Asked Questions
What is Closed Loop Glucose Control in Patients With Type 2 Diabetes?
Closed Loop Glucose Control in Patients With Type 2 Diabetes is a clinical trial registered under NCT05386849. Current status: COMPLETED.
What is the status of NCT05386849?
The current status of NCT05386849 (Closed Loop Glucose Control in Patients With Type 2 Diabetes) is: COMPLETED.
When did Closed Loop Glucose Control in Patients With Type 2 Diabetes start?
Closed Loop Glucose Control in Patients With Type 2 Diabetes started on 2022-05-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.